Skip to content
10-K/A

Annual Report

HYPERTENSION DIAGNOSTICS INC /MN

0001058828-12-000046

← back to feed
Filed
Oct 26, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2012 · Jun 30, 2012 54.15M sh
Shares Diluted FY 2012 · Jun 30, 2011 49.98M sh
Shares Outstanding FY 2012 · Jun 30, 2012 52.39M sh
Capex FY 2012 · Jun 30, 2012 −$630.53K
Stockholders Equity FY 2012 · Jun 30, 2012 −$288.67K
Stockholders Equity FY 2012 · Jun 30, 2011 $419.36K
Stockholders Equity FY 2012 · Jun 30, 2010 −$146.82K
Current Liabilities FY 2012 · Jun 30, 2012 $654.83K
Current Liabilities FY 2012 · Jun 30, 2011 $866.65K
Total Liabilities FY 2012 · Jun 30, 2012 $1.59M
Total Liabilities FY 2012 · Jun 30, 2011 $866.65K
Current Assets FY 2012 · Jun 30, 2012 $576.45K
Current Assets FY 2012 · Jun 30, 2011 $1.26M
Total Assets FY 2012 · Jun 30, 2012 $1.31M
Total Assets FY 2012 · Jun 30, 2011 $1.29M
Eps Diluted FY 2012 · Jun 30, 2012 −$0.03
Eps Diluted FY 2012 · Jun 30, 2011 $0.01
Eps Basic FY 2012 · Jun 30, 2012 −$0.03
Eps Basic FY 2012 · Jun 30, 2011 $0.01
Sga Expense FY 2012 · Jun 30, 2012 $1.25M
Sga Expense FY 2012 · Jun 30, 2011 $365.64K
Net Income FY 2012 · Jun 30, 2012 −$1.26M
Net Income FY 2012 · Jun 30, 2011 $406.31K
Operating Income FY 2012 · Jun 30, 2012 −$1.36M
Operating Income FY 2012 · Jun 30, 2011 −$365.64K
Gross Profit FY 2012 · Jun 30, 2012 −$111.85K
Cost Of Revenue FY 2012 · Jun 30, 2012 −$3.27M
Revenue FY 2012 · Jun 30, 2012 $3.16M
Cash And Equivalents FY 2012 · Jun 30, 2011 $753.88K
Cash And Equivalents FY 2012 · Jun 30, 2010 $1.05M